182 related articles for article (PubMed ID: 23398044)
1. Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.
Wetterskog D; Wilkerson PM; Rodrigues DN; Lambros MB; Fritchie K; Andersson MK; Natrajan R; Gauthier A; Di Palma S; Shousha S; Gatalica Z; Töpfer C; Vukovic V; A'Hern R; Weigelt B; Vincent-Salomon A; Stenman G; Rubin BP; Reis-Filho JS
Histopathology; 2013 Mar; 62(4):543-50. PubMed ID: 23398044
[TBL] [Abstract][Full Text] [Related]
2. Genomic landscape of adenoid cystic carcinoma of the breast.
Martelotto LG; De Filippo MR; Ng CK; Natrajan R; Fuhrmann L; Cyrta J; Piscuoglio S; Wen HC; Lim RS; Shen R; Schultheis AM; Wen YH; Edelweiss M; Mariani O; Stenman G; Chan TA; Colombo PE; Norton L; Vincent-Salomon A; Reis-Filho JS; Weigelt B
J Pathol; 2015 Oct; 237(2):179-89. PubMed ID: 26095796
[TBL] [Abstract][Full Text] [Related]
3. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
[TBL] [Abstract][Full Text] [Related]
4. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of KIT and protein kinase C-δ expression in adenoid cystic carcinoma: comparison with chromophobe renal cell carcinoma and gastrointestinal stromal tumour.
Park CK; Kim WK; Kim H
Histopathology; 2017 Oct; 71(4):529-542. PubMed ID: 28561935
[TBL] [Abstract][Full Text] [Related]
6. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
Schwartz CJ; Brogi E; Marra A; Da Cruz Paula AF; Nanjangud GJ; da Silva EM; Patil S; Shah S; Ventura K; Razavi P; Norton L; D'alfonso T; Weigelt B; Pareja F; Reis-Filho JS; Wen HY
Mod Pathol; 2022 Feb; 35(2):193-201. PubMed ID: 34599282
[TBL] [Abstract][Full Text] [Related]
7. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
Marchiò C; Weigelt B; Reis-Filho JS
J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands.
Tetsu O; Phuchareon J; Chou A; Cox DP; Eisele DW; Jordan RC
Neoplasia; 2010 Sep; 12(9):708-17. PubMed ID: 20824047
[TBL] [Abstract][Full Text] [Related]
9. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations.
Aubry MC; Heinrich MC; Molina J; Lewis JE; Yang P; Cassivi SD; Corless CL
Cancer; 2007 Dec; 110(11):2507-10. PubMed ID: 17932891
[TBL] [Abstract][Full Text] [Related]
10. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
Kim J; Lazar AJ; Davies MA; Homsi J; Papadopoulos NE; Hwu WJ; Bedikian AY; Woodman SE; Patel SP; Hwu P; Kim KB
J Cutan Pathol; 2012 Sep; 39(9):821-5. PubMed ID: 22809251
[TBL] [Abstract][Full Text] [Related]
11. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
Wen YS; Cai L; Zhang XW; Zhu JF; Zhang ZC; Shao JY; Zhang LJ
Medicine (Baltimore); 2014 Dec; 93(29):e296. PubMed ID: 25546673
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma.
Huo Z; Wu H; Li S; Liang Z
Diagn Pathol; 2015 Sep; 10():161. PubMed ID: 26373952
[TBL] [Abstract][Full Text] [Related]
13. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of lacrimal gland carcinomas and implications for treatment.
Bell D; Sniegowski MC; Wani K; Prieto V; Esmaeli B
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E724-E729. PubMed ID: 25899808
[TBL] [Abstract][Full Text] [Related]
15. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
[TBL] [Abstract][Full Text] [Related]
16. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.
Preto A; Moutinho C; Velho S; Oliveira C; Rebocho AP; Figueiredo J; Soares P; Lopes JM; Seruca R
Virchows Arch; 2007 Jun; 450(6):619-26. PubMed ID: 17487504
[TBL] [Abstract][Full Text] [Related]
17. Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel.
Schleifman EB; Tam R; Patel R; Tsan A; Sumiyoshi T; Fu L; Desai R; Schoenbrunner N; Myers TW; Bauer K; Smith E; Raja R
PLoS One; 2014; 9(3):e90761. PubMed ID: 24658394
[TBL] [Abstract][Full Text] [Related]
18. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.
Persson M; Andrén Y; Mark J; Horlings HM; Persson F; Stenman G
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18740-4. PubMed ID: 19841262
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel
Bae GE; Yoon N; Cho EY; Kim HS; Cho SY
Anticancer Res; 2019 Jan; 39(1):369-374. PubMed ID: 30591482
[TBL] [Abstract][Full Text] [Related]
20. Application of alpha-smooth muscle actin and c-kit in the differential diagnosis of adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma.
Epivatianos A; Poulopoulos A; Dimitrakopoulos I; Andreadis D; Nomikos A; Vlahou S; Papazoglou G; Barbatis C
Oral Oncol; 2007 Jan; 43(1):67-76. PubMed ID: 16807072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
